Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ·Healthcare·Biotechnology
$3.23
—
Mkt Cap $53.91M
Analyst Ratings
No recent rating data.
Price Target (5 analysts)
$9.00
Range $9.00 – $9.00
Implied Upside
+178.6%
Consensus $9.00 vs current $3.23
NASDAQ·Healthcare·Biotechnology
$3.23
—
Mkt Cap $53.91M
No recent rating data.
Price Target (5 analysts)
$9.00
Range $9.00 – $9.00
+178.6%
Consensus $9.00 vs current $3.23